MS Connect Speakers
Dr. Mark Freedman
HBSc MSc MD CSPQ FANA FAAN FRCPC
Dr. Freedman is currently professor of medicine in the field of neurology at the University of Ottawa, as well as director of the Multiple Sclerosis Research Unit at the Ottawa Hospital, General Campus and a Senior Scientist at the Ottawa Hospital Research Institute. A graduate of the University of Toronto, Dr. Freedman holds his Masters Degree in Molecular Neurochemistry and continued his postgraduate work specializing in neurology and neuroimmunology. His specialized training took him to the Weizmann Institute of Science, Israel; The National Hospital, Queen Square, London UK, as well as the Montreal Neurological Institute, where he subsequently was an Assistant Professor. He holds his specialist certification in Quebec CSPQ and all of Canada FRCP(C) and is a Fellow of both the American Neurological Association (FANA) and the American Academy of Neurology (FAAN).
Dr. Helen Tremlett
PhD, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis and Professor at the University of British Columbia, Vancouver, Canada in the Faculty of Medicine, Division of Neurology.
Dr. Tremlett’s research program is funded through operating grants from the Canadian Institutes of Health Research (CIHR), the MS Society of Canada, the MS Scientific Research Foundation, the US National MS Society among others. She is trained in pharmacoepidemiology and multiple sclerosis with a PhD from Cardiff University, UK. Her research interests include: the natural history of MS; prognosis and predictors of disease progression in MS; mortality; safety and effectiveness of the immunomodulatory drugs (IMDs) for MS; pharmacogenomics; MS epidemiology; incidence and prevalence of MS; life expectancy in MS; comorbidities and MS; pregnancy and MS; impact of parental MS on childhood developmental outcomes; health administrative data; the MS prodrome; the gut microbiome and MS. She has authored over 150 peer-reviewed papers.
Dr. Heather MacLean
Dr. Heather MacLean is an assistant professor of Neurology, a clinician investigator with the OHRI and the Director of Pre-Clerkship at the University of Ottawa School of Medicine. Her clinical focus is Multiple Sclerosis. She is a Distinguished Teacher and is passionate about medical education. She has spearheaded the development of a longitudinal Mindfulness Curriculum in UGME, has authored a book on mindfulness and is an investigator in several studies on mindfulness both within undergraduate medical education and in patients with MS.
Dr. Lisa Walker
Dr. Lisa Walker is a Clinical Neuropsychologist at both the Ottawa Hospital and in private practice at Ricci and Associates. She co-leads the Multiple Sclerosis Research Group within the University of Ottawa Brain and Mind Research Institute. She is a Clinician Investigator with the Ottawa Hospital Research Institute where she has a research program evaluating cognitive health in multiple sclerosis. Dr. Walker's research focuses on the cognitive impact of stem cell therapies, assessment and longitudinal evaluation of cognition, the relationship between cognition and both structural and functional neuroimaging variables, as well as cognitive fatigue.